DATATRAK International has announced the signing of two studies exemplifying the versatility of the DATATRAK eClinical platform.
The first is a six-year, 400-patient registry study being conducted by an academic institution to support a trial validating dynamic volume CT technology. The second is a two-year phase III study with a global pharmaceutical company utilising DATATRAK’s web-based Randomisation, Drug Inventory, EDC, Medical Coding and Lab Data Import modules for deployment across 40 sites.
Laurence Birch, chairman of DATATRAK, said: The versatility of DATATRAK’s eClinical platform is evidenced with the signing of these two studies. Whether partnering with an academic institution or a global pharmaceutical company, DATATRAK’s participation on a global level continues to expand.
The singular architecture of DATATRAK eClinical product suite has the ability to manage clinical trials through a unified multi-component, and comprehensive solution.
DATATRAK International is a technology and services company focused on the provision of multi-component eClinical solutions and related services for the clinical trials industry.
